An unwinnable fight

An unwinnable fight

Now that the 670G is in the hands of patients the question becomes how will this impact Animas, Tandem (NASDAQ: TNDM) and Insulet (NASDAQ: PODD). Or perhaps put another way who of these three will be able to withstand the impact and live to tell about it. Let’s be clear here and we cannot overstate this there is no question that the very survival of these companies is at stake here. An equally compelling question is how this event will impact a company like Bigfoot, as they may not have a system just yet but that doesn’t mean . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.